⌘K

Home/Filings/4/0001854270-24-000123

4//SEC Filing

Schulz Fran 4

Accession 0001854270-24-000123

CIK 0001854270other

View on SEC.gov Company Profile

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 4:17 PM ET

Size

5.6 KB

Accession

0001854270-24-000123

Insider Transaction Report

Form 4

Period: 2024-12-09

Senti Biosciences, Inc.SNTI

Director

Transactions

Award
Stock Option (Right to Buy)
2024-12-09+12,500→ 12,500 total
Exercise: $6.52Exp: 2034-12-08→ Common Stock (12,500 underlying)

Footnotes (1)

[F1]The shares underlying this option vest in 36 substantially equal monthly installments over three years from December 9, 2024, subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file

4
wk-form4_1733865447.xmlPrimary
FORM 4

Issuer

Senti Biosciences, Inc.

CIK 0001854270

Entity typeother

Related Parties

1

filerCIK 0002046804

Filing Metadata

Form type: 4
Filed: Dec 9, 7:00 PM ET
Accepted: Dec 10, 4:17 PM ET
Size: 5.6 KB

View on SEC.gov